Fda approves agile therapeutics, inc.’s twirla® (levonorgestrel and ethinyl estradiol) transdermal system

Twirla® is a new non-daily, non-invasive contraceptive approved in the u.s.

AGRX Ratings Summary

AGRX Quant Ranking